Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs
May 16, 2016 at 14:41 PM EDT
Revitalizing the merger and acquisition outlook for biotech sector exchange traded funds, Pfizer (NYSE: PFE) announced it will buy biopharma company Anacor Pharmaceuticals (NasdaqGS: ANAC). Pfizer paid a 55% premium to Anacor’s closing price last Friday for $5.2 billion, gaining control over...